The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: January 2020

Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development
Finance

Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development

JAN 31, 2020
Study provides first look at sperm microbiome using RNA sequencing
Pharma & Human Health

Study provides first look at sperm microbiome using RNA sequencing

JAN 31, 2020
Stopping Climate Change with Prehistoric Microbes
Phytobiome & Environment

Stopping Climate Change with Prehistoric Microbes

JAN 24, 2020
5-minute Microbiome Science Roundup: December 2019
Editor's Choice

5-minute Microbiome Science Roundup: December 2019

JAN 23, 2020
Decoding the microbiome for clinical success – Can we increase cancer immunotherapy response rate by exploring metagenomes?
Editor's Choice

Decoding the microbiome for clinical success – Can we increase cancer immunotherapy response rate by exploring metagenomes?

JAN 23, 2020
Kintai Therapeutics Advances Anti-Obesity Agent IND-Enabling Studies Following Positive Preclinical Data
Pharma & Human Health

Kintai Therapeutics Advances Anti-Obesity Agent IND-Enabling Studies Following Positive Preclinical Data

JAN 23, 2020
The future of Microbiome research: An Interview with Ted Dinan
Editor's Choice

The future of Microbiome research: An Interview with Ted Dinan

JAN 20, 2020
Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions
Oncology

Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions

JAN 15, 2020
Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127
Finance

Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127

JAN 14, 2020
Mawi and CosmosID Collaborate to Enable More Precise Microbiome Analysis
Pharma & Human Health

Mawi and CosmosID Collaborate to Enable More Precise Microbiome Analysis

JAN 13, 2020
Bayer and Azitra Partner to Harness the Human Skin Microbiome
Finance

Bayer and Azitra Partner to Harness the Human Skin Microbiome

JAN 10, 2020